Poor infrastructures have long affected medical supplies to remote areas in Uganda, due to that conundrum, Uganda has finally opted to put on a trial customized drones to deliver HIV drugs to designated patients in rural hamlets in Bugala Island.

This trial program gears toward improving the transportation of medicines in Uganda. The program is funded by the pharmaceutical company Johnson & Johnson (JNJ.N) and the government-run Infectious Diseases Institute. It dispatches HIV drugs from a hospital to patients in Kalangala an 84-island-archipelago.

After the trial passes, the government is planning to expand the drones to be used in Uganda’s public healthcare system on a larger scale.

Kalangala has an estimated 27% HIV soaring rate of the population on the islands, partially because of nomadic fishermen who move between islands.

Another reason to use this method is to tackle impediments caused by the current method of using boats that are often disrupted by storms.

“We have been facing a challenge of wind storms… the medical teams would not make it over here and some people would end up not getting their much-needed medical supplies,” Innocent Tushemerirwe, a village health team leader, told Reuters.

The trial program, which is delivering only antiretroviral at the moment, will last until June when it will be assessed.